Treating Pediatric NAFLD with Nutrition
NCT05499585 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-09-26
Summary
This is a proof of concept clinical trial to compare daily intake of at least 20 grams of whole dairy fat vs habitual diet on hepatic steatosis in children with NAFLD.
Conditions
- Non-Alcoholic Fatty Liver Disease
- Liver Diseases
- Liver Fat
- Hepatic Steatosis
- Nutritional and Metabolic Disease
Interventions
- OTHER
-
Whole Dairy
2 1/2 servings of whole dairy per day
Sponsors & Collaborators
-
University of California, San Diego
lead OTHER
Principal Investigators
-
Jeffrey Schwimmer, MD · UC San Diego
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 10 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-12
- Primary Completion
- 2024-08-15
- Completion
- 2024-09-10
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic
NCT04100109 ·Status: WITHDRAWN ·Phase: NA
-
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668 ·Status: COMPLETED ·Phase: NA
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT04634643 ·Status: RECRUITING
-
Fatty Liver Disease in Obese Children
NCT02117700 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Milk Thistle Clinical Trial in Pediatric NAFLD
NCT06477146 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Vitamin E on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00655018 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Metabolic Pathology of Pediatric NAFLD
NCT05430178 ·Status: RECRUITING ·Phase: NA
-
Hepatoprotective Measures for Children at High Risk of NAFLD
NCT06918080 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Pilot Study of Acarbose as Treatment for Pediatric Non-alcoholic Fatty Liver Disease (NAFLD)
NCT00677521 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
NCT01113567 ·Status: TERMINATED ·Phase: NA
-
Curcumin for Pediatric Nonalcoholic Fatty Liver Disease
NCT04109742 ·Status: WITHDRAWN ·Phase: PHASE2
-
Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALD
NCT02357576 ·Status: COMPLETED ·Phase: PHASE3
-
Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal Disorders
NCT01373918 ·Status: TERMINATED ·Phase: PHASE4
-
Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in Infants
NCT02420496 ·Status: WITHDRAWN ·Phase: PHASE2
-
Early Oral Nutrition in Mild Acute Pediatric Pancreatitis
NCT01423786 ·Status: TERMINATED ·Phase: NA
-
Minimization of IntraLipid Versus Omegaven
NCT01247012 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
NAFLD Pediatric Database 2
NCT01061684 ·Status: COMPLETED
-
An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption
NCT00217204 ·Status: COMPLETED ·Phase: PHASE2
-
Gemcabene for the Treatment of Pediatric NAFLD
NCT03436420 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Randomized Clinical Trial of Intravenous Lipids and Cholestasis
NCT01555957 ·Status: COMPLETED ·Phase: PHASE3
-
DHA and Vitamin D in Children With Biopsy-proven NAFLD
NCT02098317 ·Status: COMPLETED ·Phase: PHASE3
-
Compassionate Use of Omegaven in Children
NCT02370251 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Intestinal Microbiome in Obese Kids
NCT00816296 ·Status: WITHDRAWN
-
Bovine Colostrum for Patients With Non Alcoholic Fatty Liver Disease
NCT01016418 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
NCT03867487 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2